Skip to main content
. 2018 Oct 29;11:2001–2009. doi: 10.2147/IDR.S175707

Figure 1.

Figure 1

(A) Study design. (B) Proportion of the patients with HBsAg (cut-off 1,000 IU/mL) at baseline in either PEG-IFN switch-to or add-on groups.

Abbreviations: HBsAg, hepatitis B surface antigen; PEG-IFN, pegylated interferon; ETV, entecavir.